annual SGA:
$1.65B+$717.25M(+76.91%)Summary
- As of today (June 7, 2025), RDY annual SGA is $1.65 billion, with the most recent change of +$717.25 million (+76.91%) on March 1, 2025.
- During the last 3 years, RDY annual SGA has risen by +$816.43 million (+97.97%).
- RDY annual SGA is now at all-time high.
Performance
RDY SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$416.04M+$130.57M(+45.74%)Summary
- As of today (June 7, 2025), RDY quarterly SGA is $416.04 million, with the most recent change of +$130.57 million (+45.74%) on March 1, 2025.
- Over the past year, RDY quarterly SGA has increased by +$169.48 million (+68.74%).
- RDY quarterly SGA is now at all-time high.
Performance
RDY quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
N/ASummary
- RDY TTM SGA is not available.
Performance
RDY TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RDY Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +76.9% | +68.7% | - |
| 3 y3 years | +98.0% | +99.6% | - |
| 5 y5 years | +133.7% | +148.1% | - |
RDY Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +98.0% | at high | +107.2% | ||
| 5 y | 5-year | at high | +133.7% | at high | +148.1% | ||
| alltime | all time | at high | +2585.7% | at high | +2552.3% |
RDY Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | $1.65B(+76.9%) | $416.04M(+45.7%) | $1.25B(+15.7%) |
| Dec 2024 | - | $285.47M(+3.9%) | $1.08B(+4.1%) |
| Sep 2024 | - | $274.63M(+1.0%) | $1.04B(+4.8%) |
| Jun 2024 | - | $271.99M(+10.3%) | $988.80M(+6.1%) |
| Mar 2024 | $932.56M(+9.9%) | $246.56M(+1.5%) | $932.28M(+3.0%) |
| Dec 2023 | - | $242.94M(+6.9%) | $904.75M(+2.7%) |
| Sep 2023 | - | $227.31M(+5.5%) | $880.78M(+2.3%) |
| Jun 2023 | - | $215.47M(-1.6%) | $861.05M(+1.7%) |
| Mar 2023 | $848.46M(+1.8%) | $219.04M(+0.0%) | $846.39M(+1.3%) |
| Dec 2022 | - | $218.97M(+5.5%) | $835.76M(+1.6%) |
| Sep 2022 | - | $207.57M(+3.4%) | $822.38M(-0.9%) |
| Jun 2022 | - | $200.81M(-3.6%) | $830.08M(-0.4%) |
| Mar 2022 | $833.38M(+13.4%) | $208.40M(+1.4%) | $833.27M(+1.4%) |
| Dec 2021 | - | $205.59M(-4.5%) | $821.94M(+1.4%) |
| Sep 2021 | - | $215.27M(+5.5%) | $810.88M(+5.1%) |
| Jun 2021 | - | $204.01M(+3.5%) | $771.45M(+4.9%) |
| Mar 2021 | $734.81M(+4.1%) | $197.07M(+1.3%) | $735.26M(+4.2%) |
| Dec 2020 | - | $194.53M(+10.6%) | $705.87M(+2.4%) |
| Sep 2020 | - | $175.84M(+4.8%) | $689.05M(-1.7%) |
| Jun 2020 | - | $167.83M(+0.1%) | $700.61M(-0.8%) |
| Mar 2020 | $705.90M(+1.4%) | $167.68M(-5.6%) | $705.94M(-1.1%) |
| Dec 2019 | - | $177.70M(-5.2%) | $713.75M(+1.5%) |
| Sep 2019 | - | $187.40M(+8.2%) | $702.88M(+1.6%) |
| Jun 2019 | - | $173.16M(-1.3%) | $691.82M(-1.1%) |
| Mar 2019 | $695.89M(-4.3%) | $175.49M(+5.2%) | $699.25M(-1.7%) |
| Dec 2018 | - | $166.82M(-5.4%) | $711.28M(-2.7%) |
| Sep 2018 | - | $176.35M(-2.4%) | $730.68M(+0.7%) |
| Jun 2018 | - | $180.59M(-3.7%) | $725.94M(-0.2%) |
| Mar 2018 | $726.80M(+5.1%) | $187.52M(+0.7%) | $727.73M(+3.4%) |
| Dec 2017 | - | $186.22M(+8.5%) | $704.03M(+2.6%) |
| Sep 2017 | - | $171.60M(-5.9%) | $686.07M(-0.6%) |
| Jun 2017 | - | $182.38M(+11.3%) | $690.35M(-0.2%) |
| Mar 2017 | $691.53M(-1.0%) | $163.83M(-2.6%) | $691.57M(-1.2%) |
| Dec 2016 | - | $168.26M(-4.3%) | $700.04M(-2.0%) |
| Sep 2016 | - | $175.89M(-4.2%) | $714.41M(+0.8%) |
| Jun 2016 | - | $183.59M(+6.6%) | $708.85M(+1.5%) |
| Mar 2016 | $698.63M(+0.3%) | $172.30M(-5.7%) | $698.31M(+1.5%) |
| Dec 2015 | - | $182.62M(+7.2%) | $687.97M(+0.4%) |
| Sep 2015 | - | $170.34M(-1.6%) | $685.35M(-0.8%) |
| Jun 2015 | - | $173.05M(+6.8%) | $691.07M(-0.8%) |
| Mar 2015 | $696.66M(+8.2%) | $161.96M(-10.0%) | $696.56M(-0.7%) |
| Dec 2014 | - | $180.00M(+2.2%) | $701.39M(+2.9%) |
| Sep 2014 | - | $176.06M(-1.4%) | $681.74M(+2.9%) |
| Jun 2014 | - | $178.54M(+7.0%) | $662.46M(+3.2%) |
| Mar 2014 | $643.64M(+2.1%) | $166.79M(+4.0%) | $641.85M(-1.1%) |
| Dec 2013 | - | $160.36M(+2.3%) | $648.69M(+0.3%) |
| Sep 2013 | - | $156.77M(-0.7%) | $646.57M(+1.8%) |
| Jun 2013 | - | $157.93M(-9.0%) | $634.98M(+0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | $630.57M(+0.6%) | $173.64M(+9.7%) | $630.58M(+6.7%) |
| Dec 2012 | - | $158.23M(+9.0%) | $591.16M(+1.2%) |
| Sep 2012 | - | $145.18M(-5.4%) | $584.28M(-2.1%) |
| Jun 2012 | - | $153.54M(+14.4%) | $597.05M(+0.4%) |
| Mar 2012 | $626.76M(+20.5%) | $134.21M(-11.3%) | $594.73M(-0.2%) |
| Dec 2011 | - | $151.35M(-4.2%) | $596.05M(+1.5%) |
| Sep 2011 | - | $157.95M(+4.5%) | $587.03M(+6.3%) |
| Jun 2011 | - | $151.21M(+11.6%) | $551.99M(+6.0%) |
| Mar 2011 | $520.35M(+9.5%) | $135.54M(-4.8%) | $520.97M(+1.7%) |
| Dec 2010 | - | $142.33M(+15.8%) | $512.19M(+5.3%) |
| Sep 2010 | - | $122.91M(+2.3%) | $486.49M(+2.6%) |
| Jun 2010 | - | $120.19M(-5.2%) | $473.97M(-0.3%) |
| Mar 2010 | $475.14M(+3.7%) | $126.75M(+8.7%) | $475.49M(+4.5%) |
| Dec 2009 | - | $116.64M(+5.7%) | $454.89M(+1.3%) |
| Sep 2009 | - | $110.38M(-9.3%) | $448.85M(-2.1%) |
| Jun 2009 | - | $121.72M(+14.7%) | $458.25M(-0.1%) |
| Mar 2009 | $458.01M(+9.0%) | $106.15M(-4.0%) | $458.61M(-2.7%) |
| Dec 2008 | - | $110.59M(-7.7%) | $471.33M(+1.2%) |
| Sep 2008 | - | $119.78M(-1.9%) | $465.56M(+7.2%) |
| Jun 2008 | - | $122.08M(+2.7%) | $434.11M(+8.7%) |
| Mar 2008 | $420.09M(+34.4%) | $118.87M(+13.4%) | $399.42M(+11.3%) |
| Dec 2007 | - | $104.83M(+18.7%) | $358.78M(+7.2%) |
| Sep 2007 | - | $88.33M(+1.1%) | $334.61M(+2.9%) |
| Jun 2007 | - | $87.39M(+11.7%) | $325.33M(+4.3%) |
| Mar 2007 | $312.59M(+71.4%) | $78.23M(-3.0%) | $311.92M(+9.1%) |
| Dec 2006 | - | $80.66M(+2.0%) | $286.00M(+14.4%) |
| Sep 2006 | - | $79.05M(+6.9%) | $249.96M(+18.2%) |
| Jun 2006 | - | $73.98M(+41.4%) | $211.53M(+15.4%) |
| Mar 2006 | $182.43M(+20.5%) | $52.31M(+17.2%) | $183.30M(+2.2%) |
| Dec 2005 | - | $44.62M(+9.8%) | $179.33M(+5.4%) |
| Sep 2005 | - | $40.62M(-11.2%) | $170.12M(+1.8%) |
| Jun 2005 | - | $45.75M(-5.3%) | $167.05M(+5.7%) |
| Mar 2005 | $151.43M(+5.7%) | $48.33M(+36.5%) | $158.05M(+1.2%) |
| Dec 2004 | - | $35.41M(-5.7%) | $156.11M(+0.9%) |
| Sep 2004 | - | $37.55M(+2.2%) | $154.76M(+3.7%) |
| Jun 2004 | - | $36.75M(-20.8%) | $149.29M(+3.9%) |
| Mar 2004 | $143.21M(+38.5%) | $46.40M(+36.2%) | $143.75M(+12.1%) |
| Dec 2003 | - | $34.06M(+6.1%) | $128.25M(+5.3%) |
| Sep 2003 | - | $32.09M(+2.9%) | $121.73M(+5.4%) |
| Jun 2003 | - | $31.20M(+1.0%) | $115.49M(+11.5%) |
| Mar 2003 | $103.37M(+34.8%) | $30.90M(+12.1%) | $103.62M(+10.5%) |
| Dec 2002 | - | $27.55M(+6.6%) | $93.76M(+8.2%) |
| Sep 2002 | - | $25.85M(+33.8%) | $86.69M(+8.0%) |
| Jun 2002 | - | $19.32M(-8.2%) | $80.28M(+4.7%) |
| Mar 2002 | $76.70M(+24.9%) | $21.04M(+2.8%) | $76.65M(+37.8%) |
| Dec 2001 | - | $20.48M(+5.3%) | $55.61M(+58.3%) |
| Sep 2001 | - | $19.44M(+24.0%) | $35.13M(+124.0%) |
| Jun 2001 | - | $15.69M | $15.69M |
| Mar 2001 | $61.43M | - | - |
FAQ
- What is Dr Reddys Laboratories Limited annual SGA?
- What is the all time high annual SGA for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual SGA year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly SGA?
- What is the all time high quarterly SGA for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly SGA year-on-year change?
- What is the all time high TTM SGA for Dr Reddys Laboratories Limited?
What is Dr Reddys Laboratories Limited annual SGA?
The current annual SGA of RDY is $1.65B
What is the all time high annual SGA for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual SGA is $1.65B
What is Dr Reddys Laboratories Limited annual SGA year-on-year change?
Over the past year, RDY annual SGA has changed by +$717.25M (+76.91%)
What is Dr Reddys Laboratories Limited quarterly SGA?
The current quarterly SGA of RDY is $416.04M
What is the all time high quarterly SGA for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly SGA is $416.04M
What is Dr Reddys Laboratories Limited quarterly SGA year-on-year change?
Over the past year, RDY quarterly SGA has changed by +$169.48M (+68.74%)
What is the all time high TTM SGA for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high TTM SGA is $13.42B